Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
36,897,584
-
Shares change
-
-706,954
-
Total reported value, excl. options
-
$396,629,592
-
Value change
-
-$12,805,896
-
Number of buys
-
59
-
Number of sells
-
47
-
Price
-
$10.75
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q1 2019
As of 31 Mar 2019 CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) had 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,897,584 shares of stock of the company.
Largest 10 holders included BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, and BVF INC/IL.
This table shows 110 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.